Volume | 229,544 |
|
|||||
News | - | ||||||
Day High | 0.0126 | Low High |
|||||
Day Low | 0.011 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Sorrento Therapeutics Inc (CE) | SRNE | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.01215 | 0.011 | 0.0126 | 0.011 | 0.0114 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
39 | 229,544 | $ 0.01175 | $ 2,697 | - | 0.0001 - 0.08475 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:59:59 | 26 | $ 0.011 | USD |
Sorrento Therapeutics Inc (CE) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 6.06M | 551.28M | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Sorrento Therapeutics (CE) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRNE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.009 | 0.021 | 0.009 | 0.0112189 | 94,548 | 0.002 | 22.22% |
1 Month | 0.016 | 0.026 | 0.0002 | 0.0119508 | 93,975 | -0.005 | -31.25% |
3 Months | 0.016 | 0.08475 | 0.0001 | 0.0211845 | 157,925 | -0.005 | -31.25% |
6 Months | 0.016 | 0.08475 | 0.0001 | 0.0211845 | 157,925 | -0.005 | -31.25% |
1 Year | 0.016 | 0.08475 | 0.0001 | 0.0211845 | 157,925 | -0.005 | -31.25% |
3 Years | 0.016 | 0.08475 | 0.0001 | 0.0211845 | 157,925 | -0.005 | -31.25% |
5 Years | 0.016 | 0.08475 | 0.0001 | 0.0211845 | 157,925 | -0.005 | -31.25% |
Sorrento Therapeutics (CE) Description
Sorrento Therapeutics, Inc. (STI) provides access to its novel and proprietary technology platform for the construction of fully human antibody libraries, the STI Technology. The STI Technology applies RNA transcription for the amplification of human immunoglobin variable domain sequences. |